Aspira Women’s Health Inc. Net Change in Cash
Aspira Women’s Health Inc. (AWHL) reported Net Change in Cash of -$1.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$411.00K, a 126.64% decline year-over-year.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $1.54M, a 88.63% increase year-over-year.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $818.00K.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$5.77M.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$14.00K.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$1.09M.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$10.70M.
- Aspira Women’s Health Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$23.87M, a 214.78% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.28M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | -$411.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$14.00K 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$224.00K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $1.54M 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$1.09M 10-K · filed 2026-04-01 | |||
| 2024-09-30 | -$722.00K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$1.89M 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $818.00K 10-Q · filed 2025-05-19 | |||
| 2023-12-31 | -$10.70M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$8.20M 10-Q · filed 2024-11-19 | |||
| 2023-06-30 | -$9.06M 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | -$5.77M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$23.87M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$16.63M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$16.70M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$10.32M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $20.80M 10-K/A · filed 2023-10-26 | |||
| 2021-09-30 | $28.49M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $36.36M 10-Q · filed 2022-08-10 | |||
| 2021-03-31 | $42.74M 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $4.93M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $7.13M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | -$768.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | -$3.57M 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $2.34M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $5.28M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | $6.82M 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | -$3.19M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $3.82M 10-K · filed 2020-04-07 | |||
| 2018-09-30 | $6.22M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $8.60M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | -$2.44M 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $297.00K 10-K · filed 2019-03-28 | |||
| 2017-09-30 | $2.51M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | $786.00K 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $2.65M 10-Q · filed 2018-05-14 |